In Stroke, Carmelo L. Sturiale, MD, et al published findings from a systemic review and meta-analysis of endovascular treatment of intracranial aneurysms in elderly patients (2013;44:1897–1902). The investigators were from the Mayo Clinic in Rochester, Minnesota, and led by Giuseppe Lanzino, MD. They noted in the background of the study that the use of endovascular coiling for treating ruptured and unruptured intracranial aneurysms in the elderly is increasing, so they performed a meta-analysis of the literature examining clinical and angiographic outcomes.
A study presented at the Society of NeuroInterventional Surgery (SNIS) meeting (29 July–1 August, Miami, USA) suggests that the use of a balloon guide catheter with the Solitaire Stent retriever in acute ischaemic stroke results in superior recanalisation results, faster procedure time, decreased need for rescue therapy, and improved clinical outcome.
Zoll Medical Corporation (Chelmsford, MA) announced that it has purchased the assets of CoAxia, Inc. (Maple Grove, MN). Zoll Medical Corporation, which is a manufacturer of medical devices and related software solutions, is one of a diversified group of companies of the Asahi Kasei Corporation (Tokyo, Japan). CoAxia is an early revenue-stage medical device company that provides catheter-based perfusion augmentation therapies to improve outcomes for patients with cerebral ischemia resulting from vasospasm after subarachnoid hemorrhage.
Gore & Associates (Flagstaff, AZ) announced commencement of enrollment in SCAFFOLD, the Gore Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis in Patients at Increased Risk for Adverse Events from Carotid Endarterectomy.
In the case of mild or moderate strokes, getting treatment ultra-fast (within 90 minutes of experiencing symptoms) greatly reduces the risk of suffering disability, according to a new study reported in the American Heart Association’s journal, Stroke.
There is no evidence that impaired blood flow or blockage in the veins of the neck or head is involved in multiple sclerosis, says a study from McMaster University.
Data from the registry was presented at EuroPCR, Paris, France, in May 2013. The data reflects a single-centre experience of carotid artery stenting in a small cohort of 65 diabetic patients.
On 8 July, Penumbra announced the launch and wide availability of the 5Max Ace, a next generation clot extraction device that uses aspiration alone to engage and remove blood clots that cause an acute ischaemic stroke.
At the Society for Vascular Surgery (SVS) Vascular Annual Meeting (30 May–1 June 2013, San Francisco, USA), Jeffrey Jim, Washington School of Medicine, St Louis, USA, presented registry data on the differences in adverse events after carotid revascularisation between men and women with carotid artery stenosis
Dfine has announced that at the annual meeting of the American Society of Clinical Oncology (ASCO; 31 May–4 June, Chicago, USA), a study showed that its targeted radiofrequency ablation system (t-RFA; Star) was associated with safe and effective pain relief in patients with soft tissue sarcomas—highlighting successful treatment outcomes in radioresistant tumours with the system.
Researchers at Albert Einstein College of Medicine, of Yeshiva University, New York, USA, have shown, according to a press release, that football players who frequently head the ball have brain abnormalities resembling those found in patients with concussion (mild traumatic brain injury). The study, which used advanced imaging techniques and cognitive tests that assessed memory, was recently published online in the journal Radiology.
Codman Neuro has announced at the Live Interventional Neuroradiology and Neurosurgery Course (LINNC) in Paris, France, that it has obtained CE marking for the REVIVE SE, a self-expanding clot removal device for use in treating acute ischaemic stroke.
Sequent Medical announced that it has received CE Mark approval for its Single-Layer family of Web aneurysm embolisation devices and has commenced a controlled release of these new models in select neurovascular centres in Europe, according to the company.
Medically managed patients with asymptomatic severe carotid artery stenosis develop ipsilateral neurological symptoms early, according to a study presented at the Vascular Annual Meeting (30 May–1 June 2013) in San Francisco, USA. In the study, the use of statins and aspirin failed to prevent neurological symptoms.
MRI Interventions and IMRIS announced that a surgical team at a USA neuroscience institution has delivered the investigational gene therapy drug Toca 511 directly into a glioblastoma brain tumour using real-time intraoperative MRI (iMRI) guidance within an IMRIS VISIUS Surgical Theatre. MRI Interventions’ ClearPoint neurointervention system was reported as being used as the navigation platform and the ClearPoint SmartFlow large-bore cannula as the vehicle for delivery of the therapeutic agent.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos